Search

Your search keyword '"Chalmers, Elizabeth"' showing total 353 results

Search Constraints

Start Over You searched for: Author "Chalmers, Elizabeth" Remove constraint Author: "Chalmers, Elizabeth"
353 results on '"Chalmers, Elizabeth"'

Search Results

1. Obituaries

4. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

5. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT): for the EINSTEIN-Jr Cerebral Venous Thrombosis trial investigators

6. Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome

7. Biallelic Mutation of ARHGEF18, Involved in the Determination of Epithelial Apicobasal Polarity, Causes Adult-Onset Retinal Degeneration

8. Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

10. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

11. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

14. Life on the Island: Collage Portraiture and Storytelling as Community Building.

15. Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

16. Clinical and experimental studies on engraftment and chimerism following allogeneic bone marrow transplantation

18. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

20. Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

23. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

26. Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials

28. Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).

29. FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies

30. The COVID Whirlwind on the Veterinary World: End-of-life Care and Euthanasia During the COVID-19 Pandemic.

32. Abstract 9192: Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children With Congenital Heart Disease

33. Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study

35. sj-pdf-8-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

36. sj-pdf-4-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

37. sj-pdf-7-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

38. sj-pdf-9-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

39. sj-pdf-5-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

40. sj-pdf-6-tah-10.1177_20406207211007058 – Supplemental material for Expert opinion on the UK standard of care for haemophilia patients with inhibitors: a modified Delphi consensus study

42. Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update

43. Haematological evaluation of bruising and bleeding in children undergoing child protection investigation for possible physical maltreatment: A British Society for Haematology Good Practice Paper.

44. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

45. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

46. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.

47. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis

48. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis

Catalog

Books, media, physical & digital resources